🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Dylan Neel, MD PhD profiles Viswa Colluru in the latest expert interview on Biomarker. biomarker.substack.com/p/enveda-bio-v…

DermBiont raises $35.2M Series B to advance two topical skin drugs through PhII - endpts.com/dermbiont-rais…

Really nice work suggesting a role for GSDME in viral host defense in the CNS 🦠 🧠 from Soren Paludan lab ER stress induces caspase‐2‐tBID‐GSDME‐dependent cell death in neurons lytically infected with herpes simplex virus type 2 | The EMBO Journal embopress.org/doi/full/10.15…

Immunology Cheat Sheet: basic bio, clinical dev and upcoming trials for most exciting I&I assets in 2023-24. #biomarker open.substack.com/pub/biomarker/…

I enjoyed a wide-ranging discussion with Dylan Neel, MD PhD on my personal and professional journey for his BioMarker Blog. biomarker.substack.com/p/scan-health-…

Biomarker interview with Adam Koppel, Partner Bain Capital Life Sciences. #biotech #science biomarker.substack.com/p/bcls-adam-ko…

F-Prime's Alex Pasteur sat down with Dylan Neel, MD PhD to discuss his career journey, lessons learned as a life science investor, and what excites him about the future of the #radiopharmaceutical industry including our investment in ARTBIO. Learn more: bit.ly/3UanViR

Rlly cool study investigating the neuroimmunology of neuropathic pain 🧠 Congrats to the authors!

Terrific to interview Sujal Shah, CEO of CymaBay Therapeutics (Gilead Sciences) about his career and the development of Seladelpar for primary biliary cirrhosis #pbc Amazing to hear the story from Sujal! #biotech Luke Timmerman Timmerman Report timmermanreport.com/2024/04/how-cy…

Excited to share our experience with a multi-center, multi-drug expanded access program (EAP) in #ALS These programs are crucial to get novel therapies to a wider range of patients who do not qualify for RCTs Muscle & Nerve Wiley Neuro Sabrina Paganoni, MD, PhD doi.org/10.1002/mus.28…

Was a privilege to discuss #neuro drug development with Al Sandrock, and the exciting work going on Voyager Therapeutics. Check it out on #biomarker open.substack.com/pub/biomarker/…

An old dog is learning new tricks. Will be putting out a couple of rhymes with explanations each month in a series called "There is Poetry in Immunology". A couple of links below: youtube.com/watch?v=nMydLD…

Congrats to Fran Quintana Lab authors, especially Atsushi! Was happy to contribute and excited to see the link between CLEC16A and gasdermin-D #MultipleSclerosis

Happy #MatchDay! BWH Neurology and MGH Neurology are thrilled to announce our 2025 Matched Residents. We are excited to welcome the next generation of talent in medicine to #MGB. Mass General Brigham/HMS Neurology Residency

Expanded Access Protocol of RNS60 in Amyotrophic Lateral Sclerosis - a new paper from the Healey Center research team is out in Muscle & Nerve. Read it here: onlinelibrary.wiley.com/doi/10.1002/mu… #HealeyHope #ALSResearch

Beyond excited to have matched Mass General Brigham/HMS Neurology Residency ! Can’t wait to meet my co-residents, learn some cool neurology and hopefully help a lot of patients! #Neurology #Match2025 MassGeneralNeuroscience Brigham and Women's Neurology

I recently joined @Nudge as medical director. We're building a world-changing device, with the goal of precisely and non-invasively modulating brain function to improve the lives of as many people as possible.

You’re in great hands America! Here are the 2025 Harvard/MIT MD-PhD graduates who have dedicated their lives to providing the best care to your families & delivering you medical cures from their groundbreaking science. NIH Jay Bhattacharya, MD, PhD HHS.gov Secretary Kennedy Harvard Medical School Massachusetts Institute of Technology (MIT)

Biomarker interview with Dr. Eric Green, CEO of Trace Neuroscience. Eric and his team are developing a promising targeted therapy for #ALS. Check it out! #neurology #biotech open.substack.com/pub/biomarker/…

Biomarker interview Dr. Robert Baloh, Head of Neuroscience Novartis Biomedical Research. We discuss his training, exciting targets in #neurology, and challenges with #neuroscience drug development #Biotech #pharma biomarker.substack.com/p/novartis-rob…